Intimation of Trading Window Closure for the Half Year and Financial Year ending March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amwill Health Care Ltd has informed the BSE that the trading window for its securities will remain closed for all designated persons, their immediate relatives, and other insiders starting April 1, 2026, until 48 hours after the announcement of the audited financial results for the half year and financial year ending March 31, 2026 (FY25-26). This is a mandatory compliance action under SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's insider trading policy. Additionally, the PAN of designated persons will be frozen by NSDL during the closure period to prevent any trading in the company's equity shares. The date of the board meeting to approve the financial results will be announced separately.
This is a routine regulatory disclosure with no direct impact on shareholders. It signals that audited results for FY26 are upcoming, and insiders will be restricted from trading until results are publicly released, which is standard pre-results governance.